Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 17,151 | 28,301 | 29,382 | 22,766 | 41,673 |
| Gross Profit | 17,151 | 28,301 | 29,382 | 22,766 | 41,673 |
| Operating Expenses | 33,663 | 39,917 | 46,208 | 56,160 | 52,410 |
| Operating Income | -16,512 | -11,616 | -16,826 | -33,394 | -10,737 |
| Interest Expense | -3,234 | -2,567 | -2,771 | -3,213 | -3,818 |
| Other Income | -170 | -127 | -21 | 171 | -201 |
| Pre-tax Income | -13,448 | -9,176 | -14,076 | -30,010 | -7,120 |
| Income Tax | N/A | 4 | N/A | -5 | -217 |
| Net Income Continuous | -13,448 | -9,180 | -14,076 | -30,005 | -6,903 |
| Net Income | $-13,448 | $-9,180 | $-14,076 | $-30,005 | $-6,903 |
| EPS Basic Total Ops | -0.49 | -0.34 | -0.52 | -1.10 | -0.26 |
| EPS Basic Continuous Ops | -0.49 | -0.34 | -0.52 | -1.11 | -0.26 |
| EPS Diluted Total Ops | -0.49 | -0.34 | -0.52 | -1.10 | -0.26 |
| EPS Diluted Continuous Ops | -0.49 | -0.34 | -0.52 | -1.11 | -0.26 |
| EPS Diluted Before Non-Recurring Items | -0.49 | -0.34 | -0.52 | -1.11 | -0.26 |
| EBITDA(a) | $-15,749 | $-10,837 | $-16,025 | $-32,575 | $-9,825 |